{"url_path":"/sec/rigl/8-k/2026-07-01/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1034842/0001034842-26-000045-index.html","accession_number":"0001034842-26-000045","cik":"0001034842","ticker":"RIGL","issuer_name":"RIGEL PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1034842/0001034842-26-000045-index.html","primary_entity_key":"0001034842","primary_entity_name":"RIGEL PHARMACEUTICALS INC"},"word_count":209,"has_tables":true,"body_markdown":"Item 5.02.    Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.\n\nOn July 1, 2026, Rigel Pharmaceuticals, Inc. (the \"Company\") announced that Alison L. Hannah, M.D. was appointed Executive Vice President and Chief Medical Officer of the Company. In connection with her appointment, Dr. Hannah resigned from the Company’s Board of Directors (the “Board”), effective July 1, 2026.\n\nDr. Hannah had served as a member of the Board since May 2021. Since 2000, Dr. Hannah has served as a consultant to the pharmaceutical and biotechnology industry, directing the development of investigational cancer therapies. Prior to her consulting work, Dr. Hannah served as Chief Medical Officer of CytomX Therapeutics and as Senior Medical Director at SUGEN, Inc.\n\nEffective June 25, 2026, Lisa Rojkjaer, M.D. ceased serving as Executive Vice President and Chief Medical Officer of the Company and separated from the Company.\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nDated: July 1, 2026\nRIGEL PHARMACEUTICALS, INC.\n\nBy:/s/ Raymond J. Furey\n\nRaymond J. Furey\n\nExecutive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary"}